Skip to main content
Caplight Logo









Aptatek BioSciences, Inc.

Aptatek BioSciences, Inc.

Private
Princeton, New JerseyHealthcare & Life Scienceshttps://aptatek.com/

Last Round

Convertible Debt

Jun 11, 2025

Total Funding Raised

$4M

Company Overview

Aptatek BioSciences, Inc. is a medical technology company that develops portable, aptamer-based diagnostic devices for the home monitoring of chronic diseases such as phenylketonuria.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT, Patient Engagement, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsat-home testingphenylketonuriaPKUaptamer-based sensorsremote patient monitoringdigital healthbiomarker monitoringmedical devicehome diagnosticschronic disease managementmetabolic disorder testinghealth IoTRPMconnected health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aptatek BioSciences, Inc. Comparables

Compare Aptatek BioSciences, Inc. with similar companies based on industry and business-model similarity.

Aptatek BioSciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
In Vitro Diagnostic Solutions
93%
Allworth Diagnostics
89%
Kilele Health Inc.
86%

Aptatek BioSciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJun 11, 2025
SeedJun 18, 2024
SeedMar 16, 2022

Key People

Founding team and executive leadership

Michael Boyce-Jacino

CEO

Executive Team

Aptatek BioSciences, Inc. Investors

Notable investors and investment history

Aptatek BioSciences, Inc. investors
InvestorRounds
IP GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 11, 2025

    Raised funding from Canterbury Scientific.

  • Jun 18, 2024

    Led by Canterbury Scientific and National PKU Alliance.

Aptatek BioSciences, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aptatek BioSciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aptatek BioSciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range5
Year Founded2017
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?